125 related articles for article (PubMed ID: 36476308)
1. Septin9 DNA methylation as a promising biomarker for cervical cancer.
Bu Q; Luo X; He L; Ma J; He S; Lei W; Zhou W; Deng H; Lin Y; Zhang L; Hong X
J Obstet Gynaecol; 2023 Dec; 43(1):2151356. PubMed ID: 36476308
[TBL] [Abstract][Full Text] [Related]
2. PAX1 and SEPT9 methylation analyses in cervical exfoliated cells are highly efficient for detecting cervical (pre)cancer in hrHPV-positive women.
He L; Luo X; Bu Q; Jin J; Zhou S; He S; Zhang L; Lin Y; Hong X
J Obstet Gynaecol; 2023 Dec; 43(1):2179916. PubMed ID: 36799003
[TBL] [Abstract][Full Text] [Related]
3. Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes.
Guerrero-Preston R; Valle BL; Jedlicka A; Turaga N; Folawiyo O; Pirini F; Lawson F; Vergura A; Noordhuis M; Dziedzic A; Pérez G; Renehan M; Guerrero-Diaz C; De Jesus Rodríguez E; Diaz-Montes T; Rodríguez Orengo J; Méndez K; Romaguera J; Trock BJ; Florea L; Sidransky D
Cancer Prev Res (Phila); 2016 Dec; 9(12):915-924. PubMed ID: 27671338
[TBL] [Abstract][Full Text] [Related]
4. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
6. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
Verhoef VM; Heideman DA; van Kemenade FJ; Rozendaal L; Bosgraaf RP; Hesselink AT; Bekkers RL; Massuger LF; Steenbergen RD; Snijders PJ; Berkhof J; Meijer CJ
Gynecol Oncol; 2014 Oct; 135(1):58-63. PubMed ID: 25111387
[TBL] [Abstract][Full Text] [Related]
7. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
[TBL] [Abstract][Full Text] [Related]
8. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
9. [Detection and analysis of FAM19A4 promoter methylation in cervical exfoliated cells].
Wang SF; Bu QW; Zhang L; Ma JW; Heng Y; Luo JQ; Luo XP
Zhonghua Yi Xue Za Zhi; 2019 Jul; 99(25):1963-1967. PubMed ID: 31269601
[No Abstract] [Full Text] [Related]
10. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
[No Abstract] [Full Text] [Related]
11. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
[TBL] [Abstract][Full Text] [Related]
12. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection.
van den Helder R; Steenbergen RDM; van Splunter AP; Mom CH; Tjiong MY; Martin I; Rosier-van Dunné FMF; van der Avoort IAM; Bleeker MCG; van Trommel NE
Clin Cancer Res; 2022 May; 28(10):2061-2068. PubMed ID: 35266975
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.
Li N; Hu Y; Zhang X; Liu Y; He Y; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2021 Apr; 148(7):1768-1777. PubMed ID: 33300604
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women.
Bu Q; Wang S; Ma J; Zhou X; Hu G; Deng H; Sun X; Hong X; Wu H; Zhang L; Luo X
BMC Cancer; 2018 Nov; 18(1):1182. PubMed ID: 30486875
[TBL] [Abstract][Full Text] [Related]
15. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
16. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Gynecol Oncol; 2010 Jan; 116(1):99-104. PubMed ID: 19836067
[TBL] [Abstract][Full Text] [Related]
17. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
[TBL] [Abstract][Full Text] [Related]
18. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
[TBL] [Abstract][Full Text] [Related]
19. Methylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection.
Brandsma JL; Harigopal M; Kiviat NB; Sun Y; Deng Y; Zelterman D; Lizardi PM; Shabanova VS; Levi A; Yaping T; Hu X; Feng Q
Cancer Prev Res (Phila); 2014 May; 7(5):526-33. PubMed ID: 24556390
[TBL] [Abstract][Full Text] [Related]
20. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]